Van Eck Associates Corp
- SEC CIK
- 0000869178
- Latest filing
- Aug 14, 2026
NTLA holding history
Intellia Therapeutics, Inc. in every 13F filed by Van Eck Associates Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 19
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −4,622−100.0% | Sold out | Holders |
| Q1 2026 | 4,622 | $59.0K | <0.1% | −769−14.3% | Reduced | Holders |
| Q4 2025 | 5,391 | $48.0K | <0.1% | +2,751+104.2% | Added | Holders |
| Q3 2025 | 2,640 | $46.0K | <0.1% | +633+31.5% | Added | Holders |
| Q2 2025 | 2,007 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 2,007 | $14.0K | <0.1% | −181−8.3% | Reduced | Holders |
| Q4 2024 | 2,188 | $26.0K | <0.1% | +594+37.3% | Added | Holders |
| Q3 2024 | 1,594 | $32.0K | <0.1% | −594−27.1% | Reduced | Holders |
| Q2 2024 | 2,188 | $49.0K | <0.1% | +85+4.0% | Added | Holders |
| Q1 2024 | 2,103 | $58.0K | <0.1% | +161+8.3% | Added | Holders |
| Q4 2023 | 1,942 | $59.0K | <0.1% | +327+20.2% | Added | Holders |
| Q3 2023 | 1,615 | $51.0K | <0.1% | −82,927−98.1% | Reduced | Holders |
| Q2 2023 | 84,542 | $3.45M | <0.1% | +731+0.9% | Added | Holders |
| Q1 2023 | 83,811 | $3.12M | <0.1% | −9,879−10.5% | Reduced | Holders |
| Q4 2022 | 93,690 | $3.27M | <0.1% | +30,589+48.5% | Added | Holders |
| Q3 2022 | 63,101 | $3.53M | <0.1% | −21,855−25.7% | Reduced | Holders |
| Q2 2022 | 84,956 | $4.40M | <0.1% | +6,728+8.6% | Added | Holders |
| Q1 2022 | 78,228 | $5.68M | <0.1% | −1,656−2.1% | Reduced | Holders |
| Q4 2021 | 79,884 | $9.45M | <0.1% | +13,010+19.5% | Added | Holders |
| Q3 2021 | 66,874 | $8.97M | <0.1% | +66,874 | New | Holders |